Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   Matriptase/epithin participates in mammary epithelial cell growth and morphogenesis through HGF activation
  2. Lee, S. L.; Huang, P. Y.; Roller, P.; Cho, E. G.; Park, D.; Dickson, R. B.
  3. Mechanisms of Development. 2010, Jan-Feb; 127(1-2): 82-95.
  1. 2.   Oncogenic Met receptor induces ectopic structures in Xenopus embryos
  2. Ishimura, A.; Lee, H. S.; Bong, Y. S.; Saucier, C.; Mood, K.; Park, E.; Daar, I. O.
  3. Oncogene. 2006, Jul; 25(31): 4286-4299.
  1. 3.   Ink4a/Arf deficiency promotes ultraviolet radiation-induced melanomagenesis
  2. Recio, J. A.; Noonan, F. P.; Takayama, H.; Anver, M. R.; Duray, P.; Rush, W. L.; Lindner, G.; De Fabo, E. C.; DePinho, R. A.; Merlino, G.
  3. Cancer Research. 2002 62(22): 6724-6730.
  1. 4.   Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis
  2. Sharp, R.; Recio, J. A.; Jhappan, C.; Otsuka, T.; Liu, S. Q.; Yu, Y. L.; Liu, W. J.; Anver, M.; Navid, F.; Helman, L. J.; DePinho, R. A.; Merlino, G.
  3. Nature Medicine. 2002 8(11): 1276-1280.
  1. 5.   Neonatal sunburn and melanoma in mice - Severe sunburn in newborn, but not adult, mice is linked with melanoma in later life
  2. Noonan, F. P.; Recio, J. A.; Takayama, H.; Duray, P.; Anver, M. R.; Rush, W. L.; De Fabo, E. C.; Merlino, G.
  3. Nature. 2001 413(6853): 271-272.
  1. 6.   Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models
  2. Cao, B.; Su, Y. L.; Oskarsson, M.; Zhao, P.; Kort, E. J.; Fisher, R. J.; Wang, L. M.; Vande Woude, G. F.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2001 98(13): 7443-7448.
  1. 7.   Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway
  2. Danilkovitch-Miagkova, A.; Miagkov, A.; Skeel, A.; Nakaigawa, N.; Zbar, B.; Leonard, E. J.
  3. Molecular and Cellular Biology. 2001 21(17): 5857-5868.
  1. 8.   Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells
  2. Firon, M.; Shaharabany, M.; Altstock, R. T.; Horev, J.; Abramovici, A.; Resau, J. H.; Vande Woude, G. F.,; Tsarfaty, I.
  3. Oncogene. 2000 19(20): 2386-2397.
  1. 9.   Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src
  2. Nakaigawa, N.; Weirich, G.; Schmidt, L.; Zbar, B.
  3. Oncogene. 2000 19(26): 2996-3002.
  1. 10.   Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice
  2. Noonan, F. P.; Otsuka, T.; Bang, S.; Anver, M. R.; Merlino, G.
  3. Cancer Research. 2000 60(14): 3738-3743.
  1. 11.   The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-Met-urokinase plasminogen activator-plasmin proteolytic network
  2. Webb, C. P.; Hose, C. D.; Koochekpour, S.; Jeffers, M.; Oskarsson, M.; Sausville, E.; Monks, A.; Vande Woude, G. F.
  3. Cancer Research. 2000 60(2): 342-349.
  1. 12.   Macrophage stimulating protein
  2. Leonard, E. J.; Danilkovitch, A.
  3. Advances in Cancer Research, Vol 77. 2000 77: 139-167.
  1. 13.   Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy
  2. Huntsman, D.; Resau, J. H.; Klineberg, E.; Auersperg, N.
  3. American Journal of Pathology. 1999 155(2): 343-348.
  1. 14.   Identification and dynamics of a heparin-binding site in hepatocyte growth factor
  2. Zhou, H. J.; Casas-Finet, J. R.; Coats, R. H.; Kaufman, J. D.; Stahl, S. J.; Wingfield, P. T.; Rubin, J. S.; Bottaro, D. P.; Byrd, R. A.
  3. Biochemistry. 1999 38(45): 14793-14802.
  1. 15.   Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding
  2. Chirgadze, D. Y.; Hepple, J. P.; Zhou, H. J.; Byrd, R. A.; Blundell, T. L.; Gherardi, E.
  3. Nature Structural Biology. 1999 6(1): 72-79.
  1. 16.   Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype
  2. Lubensky, I. A.; Schmidt, L.; Zhuang, Z. P.; Weirich, G.; Pack, S.; Zambrano, N.; Walther, M. M.; Choyke, P.; Linehan, W. M.; Zbar, B.
  3. American Journal of Pathology. 1999 155(2): 517-526.
  1. 17.   Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells
  2. Ronen, D.; Altstock, R. T.; Firon, M.; Mittelman, L.; Sobe, T.; Resau, J. H.; Woude, G. F. V.; Tsarfaty, I.
  3. Cell Growth and Differentiation. 1999 10(2): 131-140.
  1. 18.   The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells
  2. Koochekpour, S.; Jeffers, M.; Wang, P. H.; Gong, C. N.; Taylor, G. A.; Roessler, L. M.; Stearman, R.; Vasselli, J. R.; Stetler-Stevenson, W. G.; Kaelin, W. G.; Linehan, W. M.; Klausner, R. D.; Gnarra, J. R.; Vande Woude, G. F.
  3. Molecular and Cellular Biology. 1999 19(9): 5902-5912.
  1. 19.   Alteration of Met protooncogene product expression and prognosis in breast carcinomas
  2. Tsarfaty, I.; Alvord, W. G.; Resau, J. H.; Altstock, R. T.; Lidereau, R.; Bieche, I.; Bertr, F.; Horev, J.; Klabansky, R. L.; Keydar, I.; Vande Woude, G. F.
  3. Analytical and Quantitative Cytology and Histology. 1999 21(5): 397-408.
  1. 20.   Insights Into the Structure of Hepatocyte Growth Factor Scatter Factor (Hgf/Sf) and Implications For Receptor Activation
  2. Chirgadze, D. Y.; Hepple, J.; Byrd, R. A.; Sowdhamini, R.; Blundell, T. L.; Gherardi, E.
  3. Febs Letters. 1998 430(1-2 Special Issue SI): 126-129.
  1. 21.   Mode of Receptor Binding and Activation By Plasminogen-Related Growth Factors
  2. Miller, M.; Leonard, E. J.
  3. Febs Letters. 1998 429(1): 1-3.
  1. 22.   Deficient Expression of Mrna For the Putative Inductive Factor Bone Morphogenetic Protein-7 in Chemically Initiated Rat Nephroblastomas
  2. Higinbotham, K. G.; Karavanova, I. D.; Diwan, B. A.; Perantoni, A. O.
  3. Molecular Carcinogenesis. 1998 23(2): 53-61.
  1. 23.   C-Met Autocrine Activation Induces Development of Malignant Melanoma and Acquisition of the Metastatic Phenotype
  2. Otsuka, T.; Takayama, H.; Sharp, R.; Celli, G.; Larochelle, W. J.; Bottaro, D. P.; Ellmore, N.; Vieira, W.; Owens, J. W.; Anver, M.; Merlino, G.
  3. Cancer Research. 1998 58(22): 5157-5167.
  1. 24.   The mutationally activated Met receptor mediates motility and metastasis
  2. Jeffers, M.; Fiscella, M.; Webb, C. P.; Anver, M.; Koochekpour, S.; Vande Woude, G. F.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1998 95(24): 14417-14422.
  1. 25.   Evidence For a Role of Met-Hgf/Sf During Ras-Mediated Tumorigenesis/Metastasis
  2. Webb, C. P.; Taylor, G. A.; Jeffers, M.; Fiscella, M.; Oskarsson, M.; Resau, J. H.; Woude, G. F. V.
  3. Oncogene. 1998 17(16): 2019-2025.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel